JBM (Healthcare) Limited provided unaudited consolidated earnings guidance for the year ended March 31, 2024. For the year, the company expects to record an increase in the consolidated profit attributable to Shareholders for the year ended 31 March 2024 by not less than 120% as compared to that for the year ended 31 March 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 HKD | +5.00% |
|
+7.14% | -.--% |
06-18 | JBM Healthcare Logs Higher Profit in Fiscal 2024 | MT |
06-18 | Jbm Limited Proposes Final Dividend for the Year Ended March 31, 2024, Payable on September 17, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 111M | |
+28.89% | 5.55B | |
-32.73% | 3.52B | |
-1.58% | 3.03B | |
-24.27% | 2.59B | |
-10.58% | 2.28B | |
+49.91% | 1.88B | |
+50.00% | 1.46B | |
-11.78% | 1.43B | |
+43.81% | 1.42B |
- Stock Market
- Equities
- 2161 Stock
- News JBM (Healthcare) Limited
- Jbm Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended March 31, 2024